Arkema to double its EBITDA in 2010
Arkema plans to double its EBITDA this year after a second quarter marked by record sales amid robust demand in Asia and recovery in North America.
The chemist has done on the previous quarter sales of 1.6 billion euros, up 38%.At constant perimeter, sales rose 27%.
It's his best performance since its IPO in May 2006.
"The level of first half performance allows us to review our annual target of strong EBITDA to rise, which should exceed 600 million euros (…) approximately double the EBITDA reached in 2009," said the CEO of Arkema, Thierry Le Henaff, in a statement.
In the second quarter, earnings before interest, taxes, depreciation, and amortization (EBITDA) came out to 241 million euros, more than tripling the profit for the period of 2009 and similar growth of 76% over the first three months year.
Arkema has posted a net profit group share of 119 million euros in the quarter, while it had a loss of 114 million a year earlier.
The Arkema share closed Monday at 34.985 euros, giving a market capitalization of around two billion euros. Since the beginning of the year, the stock has taken more than 30% after more than doubled in value over the whole of 2009.